Boothbay Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
+182,168
| New | +$3.05M | 0.06% | 289 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1591 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1690 |
|
|
2022
Q3 | – | Sell |
-201,811
| Closed | -$1.52M | – | 2288 |
|
|
2022
Q2 | $1.52M | Buy |
201,811
+110,263
| +120% | +$829K | 0.04% | 583 |
|
|
2022
Q1 | $860K | Buy |
91,548
+12,636
| +16% | +$119K | 0.02% | 798 |
|
|
2021
Q4 | $632K | Buy |
+78,912
| New | +$632K | 0.01% | 799 |
|
|
2020
Q2 | – | Sell |
-28,700
| Closed | -$258K | – | 989 |
|
|
2020
Q1 | $258K | Buy |
+28,700
| New | +$258K | 0.02% | 519 |
|
|
2019
Q4 | – | Sell |
-62,430
| Closed | -$430K | – | 906 |
|
|
2019
Q3 | $430K | Buy |
+62,430
| New | +$430K | 0.04% | 423 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 691 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 754 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 849 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 850 |
|
|
2015
Q4 | – | Sell |
-5,899
| Closed | -$333K | – | 617 |
|
|
2015
Q3 | $333K | Sell |
5,899
-2,715
| -32% | -$153K | 0.16% | 144 |
|
|
2015
Q2 | $509K | Buy |
8,614
+4,624
| +116% | +$273K | 0.2% | 53 |
|
|
2015
Q1 | $249K | Buy |
+3,990
| New | +$249K | 0.16% | 152 |
|